Resveratrol as a modulator of the gut-brain axis in irritable bowel syndrome
, , , , , , , y
08 oct 2024
Acerca de este artículo
Publicado en línea: 08 oct 2024
Páginas: 68 - 72
Recibido: 02 ago 2024
Aceptado: 21 sept 2024
DOI: https://doi.org/10.2478/acb-2024-0010
Palabras clave
© 2024 Bartosz Barzak et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Resveratrol, a polyphenolic compound synthesized by plants, has garnered increasing attention in recent years for its potential pharmacological applications. Notably, it has been explored as a modulator of the gut-brain axis, particularly concerning irritable bowel syndrome (IBS). IBS is a life-quality impairing condition characterized by recurrent abdominal pain associated with defecation, as well as alterations in stool frequency or form. This review provides a comprehensive overview of the role of the gut-brain axis in IBS, with a specific focus on the potential of resveratrol as a modulator of this axis and its therapeutic implications for IBS management.